Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    2.30 (2.49%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Trading Update

13 Mar 2025 07:00

RNS Number : 4372A
C&C Group Plc
13 March 2025
 

 

 

 

TRADING UPDATE FOR THE 12 MONTHS ENDED 28 FEBRUARY 2025

 

DELIVERY OF EARNINGS AND MARGIN PROGRESSION, ALONGSIDE CONTINUED STRONG CASH GENERATION

 

13 March 2025 | C&C Group plc ('C&C' or the 'Group'), a premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits and soft drinks across the UK and Ireland announces a trading update for the twelve months ended 28 February 2025 ('FY2025'). The Group's portfolio includes market-leading brands such as Tennent's, the #1 beer brand in Scotland, Bulmers the #1 cider brand in Ireland, as well as a growing collection of premium beers and ciders, together with Matthew Clark Bibendum, the leading premium drinks and wine distributor to the UK hospitality sector.

Financial Performance

Group revenues are expected to be in line with last year reflecting growth in our Distribution business offset, as highlighted at the interim results, by the impact of the disposal of our non-core soft drinks business in Ireland, the strategic exit of low margin contract brewing volume and softer GB cider sales during the important summer trading period.

The macroeconomic environment and UK October Budget have placed a degree of additional pressure on our hospitality customers and impacted consumer confidence more generally. Despite these headwinds, the Group has made good progress and expects to report underlying EBIT in the range of €76m - €78m, which although modestly below our target due to softer trading across the market in January and February, reflects significant recovery versus the prior year's earnings of €60m. Operating margins are expected to be ahead of FY2024 with positive progress in both our Branded and Distribution businesses. The Group has increased customer numbers growing 7% in the second half of FY2025 in our Matthew Clark Bibendum distribution business, reflecting further improved and consistently high service levels. We have invested in our brands and achieved market share value growth for Tennent's in both the on and off trade and for Bulmers in the ROI on trade.

Cash generation has remained strong, with net debt:EBITDA at year-end 1.0x, in line with our target, reflecting disciplined working capital management, investment in the business, and further progress in our shareholder return programme. The Group's balance sheet remains robust, providing flexibility to support future growth initiatives and capital returns to shareholders.

We have distributed €51m, comprising dividend payments of €21m and share buybacks of €30m. We intend to commence a further €15m share buyback programme on 1 May 2025.

Current Outlook

Our key commercial objectives are to support our customers with industry-leading service, choice and value, whilst continuing to delight consumers with our range of leading brands. We have some exciting plans for our brands coming in FY2026, including the relaunch of Magners as the brand is now back under our full management control in the UK market.

Looking forward, we expect to see continued uncertainty for consumers alongside the impact of the well documented challenges of the hospitality sector. We remain confident in the longer-term and will further invest in our customer proposition, brand innovation, systems and people. This underpins the Board's confidence in our ability to achieve sustainable, long-term profitable growth. We expect earnings in FY2026 to be marginally ahead of FY2025, reflecting our ongoing investment in the business to enhance our growth potential. The Group remains well-positioned to navigate these challenging conditions and our previously stated objective to deliver €100m EBIT remains in place over the medium-term.

Further details will be provided in the Group's full-year results announcement on 28 May 2025.

 

Roger White, Chief Executive Officer, commented:

 

"Having joined the business in late January 2025, although it is still early days, I believe I have already gained an understanding of the business and the wider market dynamics. It is clear to me that C&C has a committed and capable team, alongside great brands and a passion for delivering for its customers. However there is much work to be done to fully realise the potential across the Group. Whilst the market backdrop remains challenging, we are continuing to support our customers, invest in the business and have some exciting plans to implement this year which I look forward to updating you on further in May. I remain confident of the significant long-term opportunity within the business and I am fully focussed on delivering increased shareholder value."

 

 

Contacts

 

C&C Group plc

Email: investor.relations@candcgroup.ie

Investors, Analysts & UK Media:

Instinctif Partners

Justine Warren / Tim Pearson / Amelia Thorn

Tel: 020 7457 2020

Email: CandCGeneral@instinctif.com

 

Irish Media

FTI Consulting

Jonathan Neilan / Paddy Berkery / Niamh O'Brien

Tel: +353 86 231 4135 / +353 86 602 5988 / +353 87 707 8379

Email: CandCGroup@fticonsulting.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGMFVZKGKZM
Date   Source Headline
15th Feb 20247:00 amRNSDirectorate Changes
2nd Feb 202410:00 amRNSTotal Voting Rights and Capital
15th Jan 20242:20 pmRNSDirector/PDMR Shareholding
4th Jan 202412:45 pmRNSTotal Voting Rights
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
12th Dec 20231:05 pmRNSHolding(s) in Company
6th Dec 20233:30 pmRNSDirectorate Change
5th Dec 20232:10 pmRNSBlock listing Interim Review
4th Dec 202311:15 amRNSTotal Voting Rights and Capital
16th Nov 20236:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20232:56 pmRNSHolding(s) in Company
2nd Nov 202312:44 pmRNSDirector/PDMR Shareholding
31st Oct 20233:00 pmRNSTotal Voting Rights
30th Oct 20233:45 pmRNSDirector/PDMR Shareholding
26th Oct 20237:00 amBUSHalf-year Report
16th Oct 20235:16 pmRNSDirector/PDMR Shareholding
6th Oct 202312:30 pmRNSHolding(s) in Company
27th Sep 20233:56 pmRNSHolding(s) in Company
19th Sep 20237:00 amBUSStatement re FY2024 H1 pre-close Trading Statement
15th Sep 20232:10 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSDirectorate Changes
18th Aug 20239:35 amRNSDirector Declaration
16th Aug 20234:15 pmRNSDirector/PDMR Shareholding
20th Jul 20239:00 amRNSDirector Declaration
17th Jul 20233:15 pmRNSDirector/PDMR Shareholding
13th Jul 20231:00 pmRNSResult of AGM
13th Jul 20237:00 amBUSAGM Statement
6th Jul 20234:00 pmRNSHolding(s) in Company
3rd Jul 20235:45 pmRNSHolding(s) in Company
26th Jun 202312:06 pmRNSHolding(s) in Company
16th Jun 20232:00 pmRNSDirector/PDMR Shareholding
14th Jun 20236:05 pmRNSDirector/PDMR Shareholding
14th Jun 20238:30 amRNSAnnual Report & Notice of AGM
13th Jun 20234:30 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSBlock listing Interim Review
30th May 20237:00 amRNSHolding(s) in Company
26th May 202312:15 pmRNSDirector/PDMR Shareholding
24th May 20231:45 pmRNSDirector/PDMR Shareholding
24th May 202312:00 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amBUSFinal Results
19th May 20237:00 amBUSStatement re Trading Update & Directorate Changes
16th May 20232:00 pmRNSDirector/PDMR Shareholding
4th May 20231:30 pmRNSHolding(s) in Company
17th Apr 20233:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amBUSPre-close Trading Statement
16th Mar 20233:15 pmRNSDirector/PDMR Shareholding
15th Mar 20232:00 pmRNSHolding(s) in Company
23rd Feb 202311:00 amRNSHolding(s) in Company
15th Feb 20234:15 pmRNSDirector/PDMR Shareholding
10th Feb 20232:19 pmBUSStatement re Directorate Changes and Board Committee Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.